NCT04697992View on ClinicalTrials.gov

Topical Tranexamic Acid Versus Topical Vitamin C With Microneedling in Periorbital Hyperpigmentation; Comparative Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Periorbital Hyperpigmentation
Interventions
DRUG

vitamin c 20%

one eye was treated with vitamin c 20% + microneedling a session was done every 2 weeks a total of 4 sessions (other eye was placebo treated with saline + microneedling).

DRUG

Tranexamic acid 5mg/ml

one eye was treated with tranexamin acid 5 mg/ml + microneedling a session was done every 2 weeks a total of 4 sessions (other eye was placebo treated with saline + microneedling)

Trial Locations (1)

Unknown

Doaa Mohsen, Giza

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT04697992 - Topical Tranexamic Acid Versus Topical Vitamin C With Microneedling in Periorbital Hyperpigmentation; Comparative Study | Biotech Hunter | Biotech Hunter